Sotera Health expects 2024 revenue of about $1.1 billion, up nearly 5% from 2023
Sotera Health said preliminary full-year 2024 revenue is approximately $1.1 billion, growth of nearly 5% over 2023 and more than 5% on a constant currency basis. The company said the figure is within the revenue guidance it gave with its third-quarter 2024 results, but it remains subject to year-end closing procedures and audit, so final results may differ materially.
Key points
- Preliminary full-year 2024 revenue of approximately $1.1 billion, up nearly 5% versus 2023 and more than 5% on a constant currency basis
- Revenue range is within the guidance given at the third-quarter 2024 earnings release
- Chairman and CEO Michael B. Petras, Jr. presents a business update at the J.P. Morgan Healthcare Conference on January 14, 2025 at 11:15 a.m. Eastern Time
- Full 2024 results and 2025 outlook are scheduled for release on February 27, 2025
The filing
Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 14, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.